Beijing Fukangren Bio-pharmaceutical Technology Co., Ltd. is an innovative company specializing in the research and development of new drugs. Founded in 2000, the company was officially established in 2002 and is headquartered in Beijing Fengtai Science and Technology Park. Fukangren has been committed to the research and development of innovative drugs for many years, and has accumulated rich experience and resources, and is in the leading position in the field of innovative drugs in China. 2002 to date, the company has been certified as "Beijing High-tech Enterprises", "*** High-tech Enterprises", and "High-tech Enterprises". The company has been certified as "Beijing High-tech Enterprise" and "**** High-tech Enterprise", and has been awarded "Beijing International Business Incubation Center Biopharmaceutical Laboratory", "Zhongguancun Science and Technology Park Patent Engine Pilot Enterprise", and "Beijing Fengtai Science and Technology Park Extended-Release Preparation Platform".
Scientific research equipment
Fukangren's scientific research covers a total area of nearly 3,000m2, and all laboratories are equipped with small and medium-sized test equipment to meet the requirements of all stages of new drug development, and the experimental center is equipped with a large number of scientific research equipment. At the same time, we have established a wide range of business relationships with the Analysis Center of Peking University and the Capital University of Medical Science, etc, which has broadened the scientific research resources. At present, we are still actively expanding our R&D scale and resources. In 2010, Fukangren's new drug synthesis base was established and operated in Daxing District, which is equipped with advanced and comprehensive R&D equipment to ensure the smooth progress of new drug synthesis projects.
Research Fields
Fukangren is committed to the development of new drugs at home and abroad, and its business fields include the following
1. Difficult Generic Drugs: Generic drugs with a certain degree of technological difficulty
2. Generic Drugs Robo-Generic and High-Generic
3. Introduction of foreign research and development and marketed products
4, Innovative drugs: generic drugs with independent intellectual property rights
5, new formulations: extended-release formulation technology, intolerant drug formulations and fat emulsions
6, industrialization of synthetic processes
7, major synthetic process projects to improve the technology
8, the new pharmaceutical plant, workshop business consulting
9, selecting the topic of the business consulting projects
10, patent affairs business consulting
Foreign cooperation
Domestic cooperation
Fukangren based on independent innovation on the basis of a wide range of domestic and foreign research and development units and production enterprises, the formation of a technological innovation platform for the information **** enjoyment of the new technological innovation projects continue to be launched, for the company's high-end research and development of the technology to provide a wealth of material. At present, Fukangren integrates and broadens the scientific research resources, and has established a wide range of in-depth business with a number of well-known domestic institutions and more than one hundred manufacturers, and Tsinghua University, Tianjin University School of Pharmacy, Peking University, the Military Academy of Sciences, and many other scientific research institutes and colleges have long-term cooperation. Among them, the key cooperative institutions are Small Molecule Laboratory, Peptide Laboratory and Polymer Laboratory of Tsinghua University; Small Molecule Laboratory and Biologics Laboratory of Tianjin University School of Pharmacy.
In addition, we have also cooperated with hundreds of well-known domestic pharmaceutical companies.
International Cooperation
The globalization of new drug development is the tenet that Fukangren adheres to, after years of foreign exchange, Fukangren has
widely carried out a wide range of cooperation and exchanges, including:
Foreign technical cooperation in pharmaceutical preparations
Technical cooperation in the import and export of raw materials, APIs, and intermediates
Medical equipment import and export business cooperation.
Pharmaceutical import and export cooperation
Innovative drug **** co-development cooperation
At present, we have reached cooperation agreements with more than 20 foreign research institutes and enterprises
Development Concept
FuKangRen has been pursuing the belief of "Sincere Service, Scientific Innovation" since the day of its foundation. Since its inception, Fukangren has been pursuing the "sincere service, scientific innovation" belief, accumulated a number of outstanding entrepreneurs, the team sincere cooperation, innovation, all the staff of the company for the development of the company into an international innovative drug research institutions and *** with the hard work and struggle. For the development of the national pharmaceutical industry and the improvement of the national level of medication to do their duty. We strive to get rid of the confusion of generic drugs as soon as possible and achieve a qualitative leap towards the transformation of innovative drugs.
Fukangren is growing and developing, we believe that we will do better at the same time also look forward to your joining ......
Legal representative: Wang Jinjing
Establishment date: 2002-03-01
Registered capital: 1,000,000 yuan
Affiliations Region：Beijing
统一社会信用代码：91110106735583702D
经营状态：开业
所属行业：科学研究和技术服务业
公司类型：有限责任公司(自然人投资或控股)
英文名：Beijing Fukangren Biological Pharmaceutical Technology Co., Ltd.
Personnel Size: 100-499
Enterprise Address: 201, 2F, Building 5, No. 30, Jinxing Road, Daxing District, Beijing
Business Scope: Technology Development; Technology Transfer; Technology Consulting ; technical services; import and export of goods; sales of medical equipment Class I, cosmetics; sales of food. (Enterprises in accordance with the law to independently select business projects, to carry out business activities; sales of food and projects subject to approval by law, approved by the relevant departments to carry out business activities in accordance with the approved content; shall not be engaged in the city's industrial policy prohibitions and restrictions on the type of project business activities).